Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for ...

Phase I results demonstrate favorable safety, sustained target engagement, and early signs of anti-tumor activity -- Reinforce EP4 receptor antagonism as a validated, high-value strategy to overcome ...

Add Yahoo as a preferred source to see more of our stories on Google. Photo Credit: iStock Despite being known as one of the hottest states in the United States, Florida experienced an ...

New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in treating TSC-related epilepsy Filana Therapeutics to begin trading ...

Clinical studies in kidney transplantation have demonstrated that tegoprubart has the potential to improve graft survival and function while reducing the side effects associated with calcineurin ...

HOUSTON, TX, UNITED STATES, March 10, 2026 /EINPresswire.com/ — InfraPartners, an organization taking an innovative and new approach to building AI data centers ...

Cassava Sciences rebrands to Filana Therapeutics (FLNA) on March 11, 2026, focusing on filamin A CNS therapies for TSC epilepsy—get the latest update.

For years, a protein inside our cells has quietly powered billions of dollars' worth of cancer drugs. Now a team of ...

FAYETTEVILLE, GA, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- Spinal cord injury often triggers a cascade of ...

Voyager Therapeutics has hit pause on a preclinical Alzheimer’s disease program just eight months after unveiling the asset. The neurology biotech announced back in July 2025 that it was adding a new ...

Curious whether fermented blueberries are better for gut health? Dietitians explain how fermentation changes blueberries, whether it actually boosts their benefits, and why regular blueberries may ...

Restoring the gut microbiota through fecal microbiota transplantation reversed these effects. The treatment replenished CX3CR1-positive NK cells, reduced lung damage, and improved survival. Targeted ...